<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>12651</id><no>ACT17209</no><status>Open (affiliates only)</status><title>A multicenter, open-label, Phase IIb study to evaluate&#xD;
the efficacy, safety and pharmacokinetics of&#xD;
rilzabrutinib in patients with warm autoimmune&#xD;
hemolytic anemia</title><nct_id>NCT05002777</nct_id><sponsor_type>Industrial</sponsor_type><age_group>Adult</age_group><treatment_type>Treatment</treatment_type><phase>II</phase><disease_site>Other</disease_site><PI>Broome, Catherine</PI><institution>Georgetown University Medical Center; Lombardi Comprehensive Cancer Center</institution><management_group>GUMC Medicine Hem-Onc</management_group></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>